VALENCIA, Spain, March 11, 2026 /PRNewswire/ -- ARTHEx Biotech, a clinical-stage biotechnology company advancing RNA-based therapeutics for neuromuscular disorders, today announced that the U.S. Food ...

Investing.com - Jones Trading reiterated a Buy rating and $35.00 price target on Dyne Therapeutics (NASDAQ:DYN) following program updates presented at the MDA meeting. The stock currently trades at ...

Analysts have responded to these developments with mixed actions. H.C. Wainwright lowered its price target for Dyne Therapeutics to $50, citing concerns about the company’s DM1 program trials.

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...

Major software stocks like Microsoft, Oracle, and Salesforce have seen significant declines from their recent highs. Analysts are divided on whether the selloff is due to fears that AI will make ...

Colin is an Associate Editor focused on tech and financial news. He has more than three years of experience editing, proofreading, and fact-checking content on current financial events and politics.

Investors are punishing the cloud hyperscalers over rising infrastructure budgets. Some SaaS businesses are trading at valuations that appear unsustainable. AI models from Anthropic and OpenAI are ...

IT stocks globally have been under pressure for months, due to fears of AI affecting future business growth. The latest crash in prices comes on the back of Anthropic rolling out new legal tools for ...

At WSJ Invest Live, Jon Gray shared optimism for the health of the private-credit market and discussed Blackstone’s investment strategy in AI infrastructure. Investors’ fears that new developments in ...

Discover insights into mechanical keyboards, from accessories to gear, with exclusive discounts and recommendations on where to purchase high-quality products. Trump undercuts GOP push to attach SAVE ...

Software companies’ pitch to investors could use an upgrade. Once a favorite of Wall Street, software stocks have been sliding lately, with investors increasingly concerned about how the sector could ...